You could see that Rejewsky and you collaborating was an enormous boon to the whole field, and it didn't work that way with the other laboratories. And I suspect that probably was a little- It very nearly did with one bit of the American group when Max Cooper turned up, not very long afterwards, and made great friends with us all. I think, you know, courtesy of Max, I've never felt any distance from the Goode group. I think Benacerraf was a somewhat awkward customer. And John? So, in his own way, was Jacques Miller. Yes. They were a little bit less outgoing, but not much. I certainly as far as- I have no grounds for complaints. Acknowledgements were made at the time and due acknowledgements on both sides- on all sides. So one of the things that- Can I just make- sorry, excuse me interrupting. I reread for this article, for the "Nature" article, the paper which I wrote for a Dutch symposium, and I used- you and I used to discuss that article and you said- well, why don't you publish it properly. And I said- oh well it's just sitting there, I'm waiting till I'm finished this piece of research. When I looked at the Dutch- that Dutch article and I thought, as I looked at it, that I would- when I first looked at it I though, oh well this was done before Miller's paper had been published. But in that article I say, I'd heard from Melbourne about it, and that was why I was putting, you know, T-cells in the crucial figure in the way I did. So, the co-operation wasn't- the competition wasn't that bad.